Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
J Phys Ther Sci ; 31(11): 865-868, 2019 Nov.
Article in English | MEDLINE | ID: mdl-31871367

ABSTRACT

[Purpose] We evaluated the effects of functional electrical stimulation (FES) and an ankle/foot orthosis (AFO) in hemiplegic patients exhibiting excessive plantar flexion during the stance phase, associated with genu recurvatum. [Participants and Methods] In total, 12 stroke patients were recruited. We measured changes in knee and ankle joint angles, gait speed, and step and stride length during the gait cycle during barefoot walking, walking while wearing an AFO, and walking after FES application; we used a three dimensional gait analysis system. [Results] In terms of kinematic variables, FES walking was associated with significant increases in peak ankle dorsiflexion during swing, dorsiflexion angle at initial contact, peak ankle dorsiflexion during stance, knee angle at initial contact, and peak knee flexion in the loading response compared to AFO and barefoot walking. AFO walking was associated with a significant difference in peak ankle dorsiflexion during swing compared to barefoot walking. [Conclusion] FES afforded kinematic advantages to the ankle and knee joints compared to AFO in hemiplegic patients with a genu recurvatum gait.

2.
Intest Res ; 14(2): 164-71, 2016 Apr.
Article in English | MEDLINE | ID: mdl-27175117

ABSTRACT

BACKGROUND/AIMS: Rectal neuroendocrine tumors (NETs) are among the most common of gastrointestinal NETs. Due to recent advances in endoscopy, various methods of complete endoscopic resection have been introduced for small (≤10 mm) rectal NETs. However, there is a debate about the optimal treatment for rectal NETs. In our study, we aimed to evaluate the efficacy and feasibility of endoscopic resection using pneumoband and elastic band (ER-BL) for rectal NETs smaller than 10 mm in diameter. METHODS: A total of 55 patients who were diagnosed with rectal NET from January 2004 to December 2011 at Gil Medical Center were analyzed retrospectively. Sixteen patients underwent ER-BL. For comparison, 39 patients underwent conventional endoscopic mucosal resection (EMR). RESULTS: There was a markedly lower deep margin positive rate for ER-BL than for conventional EMR (6% [1/16] vs. 46% [18/39], P=0.029). Four patients who underwent conventional EMR experienced perforation or bleeding. However, they recovered within a few days. On the other hand, patients whounderwent endoscopic resection using a pneumoband did not experience any complications. In multivariate analysis, ER-BL (P=0.021) was independently associated with complete resection. CONCLUSIONS: ER-BL is an effective endoscopic treatment with regards to deep margin resection for rectal NET smaller than 10 mm.

3.
Korean J Gastroenterol ; 63(5): 292-8, 2014 May.
Article in Korean | MEDLINE | ID: mdl-24870301

ABSTRACT

BACKGROUND/AIMS: Nonalcoholic fatty liver disease (NAFLD) may be one of the important causes of cryptogenic hepatocellular carcinoma (HCC). The aim of this study was to evaluate whether patients with cryptogenic HCC share clinical features similar to that of NAFLD. METHODS: Cryptogenic HCC was defined as HCC that occurs in patients with the following conditions: HBsAg(-), anti-HCV(-), and alcohol ingestion of less than 20 g/day. All patients diagnosed with cryptogenic HCC from 2005 to 2012 (cryptogenic HCC group), and all patients diagnosed with HBV associated HCC between 2008 and 2012 (HBV-HCC group) were enrolled in the present study. Clinical features, BMI, lipid profiles, presence of diabetes mellitus, hypertension, and metabolic syndrome were compared between the two groups. RESULTS: Cryptogenic HCC group was composed of 35 patients (19 males and 16 females) with a mean age of 70 ± 11 years. HBV-HCC group was composed of 406 patients (318 males and 88 females) with a mean age of 56 ± 7 years. Patients in the cryptogenic HCC group were older (p=0.001) and female dominant (p=0.042) than those in the HBV-HCC group. There were no differences in the laboratory test results including lipid profiles and Child-Turcotte-Pugh class between the two groups. Patients in the cryptogenic HCC group had higher prevalence of diabetes (37% vs. 17%, p=0.015), hypertension (49% vs.27%, p=0.051), metabolic syndrome (37% vs. 16%, p=0.001), and higher BMI (25.3 kg/m(2) vs. 24.1 kg/m(2), p=0.042) than those in the HBV- HCC group. The tumor stage was more advanced (stage III and IV) at diagnosis in the cryptogenic HCC group than in the HBV-HCC group (60% vs. 37%, p=0.007). CONCLUSIONS: Cryptogenic HCC has clinical features similar to that of NAFLD and is diagnosed at a more advanced tumor stage.


Subject(s)
Carcinoma, Hepatocellular/diagnosis , Liver Neoplasms/diagnosis , Non-alcoholic Fatty Liver Disease/diagnosis , Age Factors , Aged , Body Mass Index , Carcinoma, Hepatocellular/etiology , Carcinoma, Hepatocellular/pathology , Diabetes Complications , Diabetes Mellitus/pathology , Female , Hepatitis B/complications , Humans , Hypertension/complications , Lipids/blood , Liver Neoplasms/etiology , Liver Neoplasms/pathology , Male , Metabolic Syndrome/complications , Middle Aged , Neoplasm Staging , Non-alcoholic Fatty Liver Disease/pathology , Risk Factors , Severity of Illness Index , Sex Factors
4.
Korean J Intern Med ; 29(3): 307-14, 2014 May.
Article in English | MEDLINE | ID: mdl-24851065

ABSTRACT

BACKGROUND/AIMS: The Ministry of Health and Welfare and the Korea Centers for Disease Control and Prevention in South Korea have been organizing hepatitis B virus (HBV) vertical infection prevention projects since July 2002. In this single-institute study, the results of surveys conducted in target mothers who delivered babies in a tertiary hospital were investigated and analyzed. METHODS: Of the 9,281 mothers and their 9,824 neonates born between July 2002 and December 2012, 308 hepatitis B surface antigen (HBsAg)-positive mothers and their 319 neonates were selected for this study, and their records were analyzed retrospectively. RESULTS: A total of 308 mothers were HBsAg-positive, with an HBV prevalence of 3.32% (308/9,281). There were 319 neonates born to these HBsAg-positive mothers, and 252 were confirmed to as either HBsAg-positive or -negative. Four were confirmed as HBsAg-positive, with a 1.59% (4/252) HBV vertical infection rate. All the mothers of neonates who had an HBV vertical infection were hepatitis B e antigen (HBeAg)-positive. Among the HBsAg-positive neonates, three were HBeAg-positive and had an HBV DNA titer of 1.0 × 10(8) copies/mL. CONCLUSIONS: The HBV prevalence of mothers was 3.32% (308/9,281), and their vertical infection rate was 1.59% (4/252). Thus, the South Korean HBV vertical infection prevention projects are effective, and, accordingly, HBV prevalence in South Korea is expected to decrease continuously.


Subject(s)
Hepatitis B/transmission , Infectious Disease Transmission, Vertical , National Health Programs , Tertiary Care Centers , Adult , Biomarkers/blood , DNA, Viral/blood , Female , Health Surveys , Hepatitis B/blood , Hepatitis B/diagnosis , Hepatitis B/epidemiology , Hepatitis B/prevention & control , Hepatitis B/virology , Hepatitis B Surface Antigens/blood , Hepatitis B e Antigens/blood , Hepatitis B virus/genetics , Hepatitis B virus/immunology , Humans , Infant, Newborn , Infectious Disease Transmission, Vertical/prevention & control , Pregnancy , Prevalence , Republic of Korea/epidemiology , Retrospective Studies , Viral Load
5.
J Korean Med Sci ; 28(8): 1213-9, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23960450

ABSTRACT

TWO VARIANTS OF THE INOSINE TRIPHOSPHATASE (ITPA: rs1127354, rs7270101) gene cause ITPA deficiency and protect against the hemolytic toxicity of ribavirin. We investigated the clinical significance of ITPA variants in Korean patients treated with pegylated interferon (PEG-IFN) plus ribavirin. Of the 133 patients, 108 were CC and 25 were non-CC at rs1127354 (groups A and B, respectively). On the other hand, at rs7270101 all 133 were AA. The mean values of Hemoglobin (Hgb) after 4, 8, and 12 weeks of treatment in groups A and B were 12.2 and 14.0, 11.8 and 13.2, and 11.5 and 12.9, respectively (P=0.001, 0.036, 0.036). Sustained virologic response (SVR) was achieved in 67.8% (40/59) of genotype 1 patients and in 75% (27/36) of non-genotype 1 patients. Regarding ITPA variants, SVR was achieved by 66% and 80% of genotype 1 (P=0.282), and by 78% and 71% (P=0.726) of non-genotype 1. SVR was not significantly different in groups A and B. In conclusion, non-CC at rs1127354 without involvement of rs7270101 is strongly associated with protection from ribavirin-induced anemia, however, ITPA genotype is not associated with SVR.


Subject(s)
Asian People/genetics , Hemoglobins/analysis , Hepatitis C, Chronic/genetics , Pyrophosphatases/genetics , Adult , Alleles , Antiviral Agents/therapeutic use , Cohort Studies , Drug Therapy, Combination , Female , Genotype , Hemolysis , Hepacivirus/genetics , Hepatitis C, Chronic/drug therapy , Humans , Interferon-alpha/therapeutic use , Interferons , Interleukins/genetics , Male , Middle Aged , Polyethylene Glycols/therapeutic use , Recombinant Proteins/therapeutic use , Republic of Korea , Retrospective Studies , Ribavirin/therapeutic use , Treatment Outcome , Inosine Triphosphatase
6.
Nutr Res ; 33(8): 677-85, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23890358

ABSTRACT

Increased acid output, accompanied with a defective defense system, is considered a fundamental pathogenesis of duodenal ulcer (DU). However, relapse of DU occurs despite proton pump inhibitors and H2 receptor antagonists, hence imposing the enforcement of the defense system. Dried powder of the yam tuber (Dioscorea spp) has been used in traditional folk medicine as a nutritional fortification. We hypothesized that dried-yam powder would prevent DU through improvement of anti-inflammatory actions and carbonic anhydrase (CA) activity. Therefore, we investigated the preventive effects of dried-yam powder against the cysteamine-induced DU and elucidated the underlying mechanisms. Duodenal ulcers were induced in Sprague-Dawley rats by intragastric administration of 500 mg/kg cysteamine-HCl. The dried-yam powder was used as a pretreatment before the cysteamine-HCl. The number and size of DU were measured. The expressions of inflammation mediators were checked in duodenal tissues, and the expressions of CAs and malondialdehyde levels were also examined. Cysteamine provoked perforated DU, whereas dried-yam powder significantly prevented DU as much as pantoprazole and significantly reduced the incidence of perforation. The messenger RNA expressions of cyclooxygenase-2 and inducible nitric oxide synthase were remarkably decreased in the yam group compared with the cysteamine group, and the serum levels of proinflammatory cytokines including interleukin-1ß, interleukin-6, and tumor necrosis factor were significantly attenuated in the yam group. Cysteamine significantly decreased the expression of CAs, whereas yam treatment significantly preserved the expressions of CA IX, XII, and XIV. In conclusion, dried-yam powder exerts a significant protective effect against cysteamine-induced DU by lowering the activity of inflammatory cytokines and free radicals and restoring the activity of CAs, except in CA IV.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Anti-Ulcer Agents/therapeutic use , Carbonic Anhydrases/metabolism , Dioscorea , Duodenal Ulcer/drug therapy , Phytotherapy , Plant Preparations/therapeutic use , 2-Pyridinylmethylsulfinylbenzimidazoles/therapeutic use , Animals , Anti-Inflammatory Agents/pharmacology , Anti-Ulcer Agents/pharmacology , Cyclooxygenase 2/genetics , Cyclooxygenase 2/metabolism , Cyclooxygenase 2 Inhibitors/pharmacology , Cyclooxygenase 2 Inhibitors/therapeutic use , Cysteamine , Cytokines/blood , Disease Models, Animal , Duodenal Ulcer/chemically induced , Duodenal Ulcer/metabolism , Inflammation Mediators/metabolism , Male , Nitric Oxide Synthase Type II/genetics , Nitric Oxide Synthase Type II/metabolism , Pantoprazole , Plant Preparations/pharmacology , Plant Tubers , Powders , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley
7.
Korean J Gastroenterol ; 60(5): 306-14, 2012 Nov.
Article in Korean | MEDLINE | ID: mdl-23172279

ABSTRACT

BACKGROUND/AIMS: A combination of peginterferon and ribavirin is the standard therapy for chronic hepatitis C (CHC). However, the respective study has not been carried out in a large scale in Korea. The purpose of this study was to collect the studies that have been reported in Korea in order to analyze the therapeutic effect of combination therapy and compare to find racial difference. METHODS: Twenty-eight papers related to the therapeutic effect of combination therapy in CHC patients were analyzed based on pooled analysis. RESULTS: Based on the analysis for genotype 1 in Korea, early virologic response (EVR), end of treatment response (ETR), and sustained virologic response (SVR) were 79.6% (125/157), 80.1% (166/207), and 62.7% (341/543). The EVR, ETR, and SVR for genotype 2 and 3 were 89.4% (119/133), 92.2% (203/220), and 84.1% (434/516). Data from other Asians showed that EVR and SVR for genotype 1 were 88.9% (290/326) and 64.4% (491/762) respectively and 88.8% (135/152), and 79.4% (151/190) for genotype 2 and 3 respectively. In Western, EVR and SVR for genotype 1 were 51.3% (1,981/3,860) and 42.4% (1,798/4,231) respectively, and for genotype 2 and 3 were 87.7% (350/399) and 77.8% (533/685) respectively. Based on the comparative analysis, no statistical difference in SVR between Koreans and other Asians (p=0.955) was observed; However, the SVR of Koreans was higher with significance than that of Westerns (p<0.001) On the other hand, there was no difference what so ever, in SVR for genotype 2 amongst the different races. CONCLUSIONS: The SVR of combination therapy for the Korean chronic hepatitis C patients was similar to other Asians but higher than Westerns.


Subject(s)
Antiviral Agents/therapeutic use , Hepatitis C, Chronic/drug therapy , Interferon-alpha/therapeutic use , Polyethylene Glycols/therapeutic use , Ribavirin/therapeutic use , Databases, Factual , Drug Therapy, Combination , Genotype , Hepacivirus/genetics , Hepatitis C, Chronic/ethnology , Humans , Interferon alpha-2 , Recombinant Proteins/therapeutic use , Treatment Outcome
8.
Korean J Hepatol ; 18(1): 94-7, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22511909

ABSTRACT

An 80-year-old woman with hilar cholangiocarcinoma was hospitalized due to sudden-onset abdominal pain. Computed tomography revealed hepatic necrosis accompanied with emphysematous change in the superior segment of the right liver (S7/S8), implying spontaneous rupture, based on the presence of perihepatic free air. Although urgent percutaneous drainage was performed, neither pus nor fluids were drained. These findings suggest emphysematous hepatitis with a hepatic mass. Despite the application of intensive care, the patient's condition deteriorated rapidly, and she died 3 days after admission to hospital. Liver gas has been reported in some clinical diseases (e.g., liver abscess) to be caused by gas-forming organisms; however, emphysematous hepatitis simulating emphysematous pyelonephritis is very rare. The case reported here was of fatal emphysematous hepatitis in a patient with hilar cholangiocarcinoma.


Subject(s)
Cholangiocarcinoma , Emphysema/diagnosis , Hepatitis/diagnosis , Pneumoperitoneum , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Bile Duct Neoplasms/complications , Bile Duct Neoplasms/diagnosis , Bile Ducts, Intrahepatic/pathology , Cefotaxime/therapeutic use , Cholangiocarcinoma/complications , Cholangiocarcinoma/diagnosis , Clostridium Infections/drug therapy , Clostridium Infections/microbiology , Clostridium perfringens/isolation & purification , Emphysema/complications , Escherichia coli/isolation & purification , Escherichia coli Infections/drug therapy , Escherichia coli Infections/microbiology , Female , Hepatitis/complications , Humans , Metronidazole/therapeutic use , Pneumoperitoneum/complications , Pneumoperitoneum/diagnosis , Tomography, X-Ray Computed
9.
Korean J Hepatol ; 17(3): 229-32, 2011 Sep.
Article in English | MEDLINE | ID: mdl-22102391

ABSTRACT

Amoxicillin, an antibiotic that is widely prescribed for various infections, is associated with a very low rate of drug-induced liver injury; hepatitis and cholestasis are rare complications. Here we present a case of a 39-year-old woman who was diagnosed with abdominal actinomycosis and received amoxicillin treatment. The patient displayed hepatocellular and bile-duct injury, in addition to elevated levels of liver enzymes. The patient was diagnosed with amoxicillin-induced cholestatic hepatitis. When amoxicillin was discontinued, the patient's symptoms improved and her liver enzyme levels reduced to near to the normal range.


Subject(s)
Amoxicillin/adverse effects , Anti-Bacterial Agents/adverse effects , Chemical and Drug Induced Liver Injury/diagnosis , Cholestasis/chemically induced , Actinomycosis/drug therapy , Adult , Alanine Transaminase/blood , Alkaline Phosphatase/blood , Aspartate Aminotransferases/blood , Chemical and Drug Induced Liver Injury/etiology , Female , Humans , Liver/enzymology
10.
Korean J Gastroenterol ; 58(4): 201-7, 2011 Oct 25.
Article in Korean | MEDLINE | ID: mdl-22042420

ABSTRACT

BACKGROUND/AIMS: Periampullary diverticulum (PAD) causes difficulty in the extraction of common bile duct (CBD) stones with conventional endoscopic therapy. Our study was designed to evaluate the effect of PAD on endoscopic large balloon dilation (EPLBD) with/without limited endoscopic sphincterotomy (EST) for CBD stone treatment. METHODS: We retrospectively reviewed cases of 141 patients treated CBD stones by EPLBD with/without limited EST at Gachon Gil Medical Center from September 2008 to February 2010. PAD were classified into three groups according to the location of the papilla and diverticulum. Clinical parameters, endoscopic parameters, and procedure outcomes were analyzed. RESULTS: PAD were identified in 46.1% (65/141), with 23 male (35.4%) and 42 female (64.6%) and a mean age of 72.9±11.1 years. Mean diameter of the stones was 14.8±6.0 mm and mean diameter of CBD was 21.6±7.7 mm. PAD group was significantly older than control group (72.9 vs. 68.6, p=0.043) and the incidence of large stone (≥15 mm) was higher in PAD group (60.0% vs. 42.1%, p=0.034). Success rate of complete removal of stones in the first session was 32/65 patients (49.2%) and overall successful complete stone removal rates was 63/65 (96.9%). There was no significant difference between the PAD and control groups in success rate. Major complications were similar between two groups. CONCLUSIONS: PAD is associated with an increased incidence of large bile duct stones and older age. PAD seems to not increase technical failure rate or complication risk on EPLBD with/without limited EST.


Subject(s)
Catheterization , Diverticulum/diagnosis , Duodenal Diseases/diagnosis , Gallstones/therapy , Age Factors , Aged , Aged, 80 and over , Cholangiopancreatography, Endoscopic Retrograde , Common Bile Duct/anatomy & histology , Female , Gallstones/surgery , Humans , Male , Middle Aged , Retrospective Studies , Treatment Outcome
11.
Int J Cardiol ; 143(3): e57-9, 2010 Sep 03.
Article in English | MEDLINE | ID: mdl-19324438

ABSTRACT

Carotid plaque is a marker of subclinical atherosclerosis that predicts the presence of coronary artery disease and cardiovascular events. The patient complained of chest discomfort accompanied by ECG abnormalities. Treadmill test demonstrated horizontal ST segment depression, however, coronary angiography did not show any significant stenosis. Carotid plaque was detected by carotid ultrasonogram, despite of the absence of any traditional and non-traditional cardiovascular risk factors, especially normal lipid profiles. This case suggests that unknown determinants of carotid atherosclerosis that we cannot elucidate from the history, physical examination, and common laboratory tests may play a role in the development of carotid plaque.


Subject(s)
Carotid Artery Diseases/diagnostic imaging , Carotid Artery Diseases/epidemiology , Plaque, Atherosclerotic/diagnostic imaging , Plaque, Atherosclerotic/epidemiology , Coronary Angiography , Echocardiography , Electrocardiography , Exercise Test , Female , Humans , Middle Aged , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...